☆ 4.7 Article

B cell-intrinsic Myd88 regulates disease progression in murine lupus

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Immunology

Age-associated B cells are heterogeneous and dynamic drivers of autoimmunity in mice

Kevin M. Nickerson et al.

Summary: Age-associated B cells (ABCs) are a type of memory B cell expressing the transcription factor T-bet, formed under inflammatory conditions. In systemic lupus erythematosus (SLE), ABC frequency is correlated with disease and they are considered the source of autoantibody-secreting cells. The heterogeneity of ABCs and their relationship to other B cell subsets such as plasmablasts is unclear. The study shows that ABCs are dynamic and can be plasmablast precursors or undergo cycles of reactivation. Deletion of CD11c-expressing B cells reveals a direct role for ABC-like B cells in lupus pathogenesis.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Add to Collection

News Item Dermatology

CD19 CAR T cell therapy effective for systemic lupus erythematosus

J. Gelfand

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Add to Collection

Article Immunology

Loss of interleukin-1 beta is not protective in the lupus-prone NZM2328 mouse model

Shannon N. Loftus et al.

Summary: Abnormal activation of the immune system is a known cause of lupus. Inhibiting the inflammasome and its downstream components has been shown to reduce disease severity in lupus mouse models. This study examines the effects of IL-1 beta loss on disease severity in a lupus-prone mouse model and identifies potential clinical relevance of TNF and IL-17 signaling pathways. Caution may be needed when inhibiting inflammasome or IL-1 beta signaling in SLE, especially in patients with renal involvement.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Rheumatology

B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial

Richard A. Furie et al.

Summary: This study compared the efficacy of obinutuzumab with standard therapies and placebo in the treatment of LN. The results showed that obinutuzumab achieved better complete renal responses at 52 and 104 weeks compared to standard therapies alone. It also showed improvements in other renal response measures, serologies, estimated glomerular filtration rate and proteinuria. Obinutuzumab was well tolerated and no new safety signals were identified.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection

Article Urology & Nephrology

A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis

Brad H. Rovin et al.

Summary: Belimumab was found to be most effective in improving kidney response in patients with proliferative lupus nephritis and baseline urine protein/creatinine ratio under 3 g/g. However, it did not show improvement in kidney response in patients with lupus nephritis and sub-epithelial deposits or with a baseline protein/creatinine ratio of 3 g/g or more.

KIDNEY INTERNATIONAL (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Age-associated B cells in autoimmune diseases

Isobel C. Mouat et al.

Summary: Age-associated B cells (ABCs) are a unique population of B cells that are associated with age, infection, and autoimmune diseases. The exact impact of ABCs on diseases remains unclear.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Add to Collection

Article Immunology

Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus

Claire Leibler et al.

Summary: In lupus, TLR9 has two protective functions: one ligand-independent and MyD88-independent function, and another ligand-dependent but MyD88-independent regulatory and MyD88-mediated proinflammatory function. These functions are B cell intrinsic and restrained differentiation into pathogenic age-associated B cells and plasmablasts. This study sheds light on the biology of endosomal TLRs.

NATURE IMMUNOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

Andreas Mackensen et al.

Summary: A study of five patients with refractory systemic lupus erythematosus treated with anti-CD19 CAR T cell therapy showed remission of SLE disease in all patients after 3 months, and long-term drug-free remission was maintained during follow-up.

NATURE MEDICINE (2022)

Add to Collection

Review Rheumatology

Toll-like receptor signalling in B cells during systemic lupus erythematosus

Simon Fillatreau et al.

Summary: Loss of B cell tolerance to autoantigens in systemic lupus erythematosus (SLE) is driven by TLR7, whereas TLR9 appears to protect against SLE by limiting the stimulatory activity of TLR7. The unique features of Toll-like receptor signaling in B cells implicate it as a therapeutic target in SLE.

NATURE REVIEWS RHEUMATOLOGY (2021)

Add to Collection

Review Immunology

Toll-Like Receptors Gene Polymorphisms in Autoimmune Disease

Yingchi Zhang et al.

Summary: Toll-like receptor gene polymorphisms can increase the risk of autoimmune diseases, and studying these variations can expand our understanding of the pathogenesis of autoimmune diseases.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Altered function and differentiation of age-associated B cells contribute to the female bias in lupus mice

Edd Ricker et al.

Summary: This study demonstrates that age-associated B cells (ABC) play a crucial role in sex-specific autoimmune diseases, particularly in the development of lupus-like syndrome in females. The absence of certain guanine exchange factors in double-knock-out (DKO) mice leads to the accumulation of ABCs, which differentiate into pathogenic effector B cell populations with pro-inflammatory function. The upregulation of Tlr7 in DKO males further enhances the dissemination and pathogenicity of ABCs, resulting in severe pulmonary inflammation and early mortality.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Immunology

An update on genetic susceptibility in lupus nephritis

Kangkang Song et al.

CLINICAL IMMUNOLOGY (2020)

Add to Collection

Article Medicine, Research & Experimental

B cell-intrinsic TLR9 expression is protective in murine lupus

Jeremy S. Tilstra et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Article Medicine, General & Internal

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

Richard Furie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Immunology

Extrafollicular responses in humans and SLE

Scott A. Jenks et al.

IMMUNOLOGICAL REVIEWS (2019)

Add to Collection

Article Cell Biology

Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus

Rita Kansal et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Add to Collection

Review Immunology

Genetic variation and systemic lupus erythematosus: A field synopsis and systematic meta-analysis

Dong Yeon Jeong et al.

AUTOIMMUNITY REVIEWS (2018)

Add to Collection

Article Medicine, Research & Experimental

Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted

Jeremy S. Tilstra et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Add to Collection

Article Immunology

Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus

Scott A. Jenks et al.

IMMUNITY (2018)

Add to Collection

Article Immunology

TLR7 escapes X chromosome inactivation in immune cells

Melanie Souyris et al.

SCIENCE IMMUNOLOGY (2018)

Add to Collection

Article Medicine, Research & Experimental

B cells expressing the transcription factor T-bet drive lupus-like autoimmunity

Kira Rubtsova et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Add to Collection

Article Rheumatology

T-bet+ CD11c+ B cells are critical for antichromatin immunoglobulin G production in the development of lupus

Ya Liu et al.

ARTHRITIS RESEARCH & THERAPY (2017)

Add to Collection

Article Medicine, Research & Experimental

Lupus and proliferative nephritis are PAD4 independent in murine models

Rachael A. Gordon et al.

JCI INSIGHT (2017)

Add to Collection

Article Medicine, Research & Experimental

Autoreactive helper T cells alleviate the need for intrinsic TLR signaling in autoreactive B cell activation

Josephine R. Giles et al.

JCI INSIGHT (2017)

Add to Collection

Article Immunology

B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus

Jing Wen et al.

JOURNAL OF NEUROINFLAMMATION (2016)

Add to Collection

Article Rheumatology

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

Tobias Alexander et al.

ANNALS OF THE RHEUMATIC DISEASES (2015)

Add to Collection

Article Immunology

B Cell-Specific MHC Class II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine Lupus

Josephine R. Giles et al.

JOURNAL OF IMMUNOLOGY (2015)

Add to Collection

Article Immunology

Dosage of X- linked Toll- like receptor 8 determines gender differences in the development of systemic lupus erythematosus

Benjamin R. Umiker et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population

Chin-Man Wang et al.

SCIENTIFIC REPORTS (2014)

Add to Collection

Article Immunology

Signals via the Adaptor MyD88 in B Cells and DCs Make Distinct and Synergistic Contributions to Immune Activation and Tissue Damage in Lupus

Lino L. Teichmann et al.

IMMUNITY (2013)

Add to Collection

Article Rheumatology

Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study

Brad H. Rovin et al.

ARTHRITIS AND RHEUMATISM (2012)

Add to Collection

Article Multidisciplinary Sciences

B Cell Receptor Signal Transduction in the GC Is Short-Circuited by High Phosphatase Activity

Ashraf M. Khalil et al.

SCIENCE (2012)

Add to Collection

Article Hematology

Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity

Anatoly V. Rubtsov et al.

BLOOD (2011)

Add to Collection

Article Immunology

An Acquired Defect in IgG-Dependent Phagocytosis Explains the Impairment in Antibody-Mediated Cellular Depletion in Lupus

Anupama Ahuja et al.

JOURNAL OF IMMUNOLOGY (2011)

Add to Collection

Article Immunology

Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines

Alenka Kuznik et al.

JOURNAL OF IMMUNOLOGY (2011)

Add to Collection

Review Rheumatology

Long-lived autoreactive plasma cells drive persistent autoimmune inflammation

Falk Hiepe et al.

NATURE REVIEWS RHEUMATOLOGY (2011)

Add to Collection

Article Immunology

TLR9 Regulates TLR7-and MyD88-Dependent Autoantibody Production and Disease in a Murine Model of Lupus

Kevin M. Nickerson et al.

JOURNAL OF IMMUNOLOGY (2010)

Add to Collection

Article Multidisciplinary Sciences

Pyogenic bacterial infections in humans with MyD88 deficiency

Horst von Bernuth et al.

SCIENCE (2008)

Add to Collection

Article Immunology

Depletion of B cells in murine lupus: Efficacy and resistance

Anupama Ahuja et al.

JOURNAL OF IMMUNOLOGY (2007)

Add to Collection

Article Rheumatology

Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice

Atsushi Sadanaga et al.

ARTHRITIS AND RHEUMATISM (2007)

Add to Collection

Article Immunology

Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus

Sean R. Christensen et al.

IMMUNITY (2006)

Add to Collection

Article Genetics & Heredity

Genomic view of systemic autoimmunity in MRLlpr mice

J Liu et al.

GENES AND IMMUNITY (2006)

Add to Collection

Article Rheumatology

Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies

ZM Sthoeger et al.

ANNALS OF THE RHEUMATIC DISEASES (2003)

Add to Collection

Article Immunology

Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice

WM Wu et al.

IMMUNOLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.